https://en.triplepharm.by/%D0%A1%D0%B5%D1%80%D1%82%D0%B8%D1%84%D0%B8%D0%BA%D0%B0%D1%82%20GMP%20%D0%91%D0%B5%D0%BB.pdf
https://en.triplepharm.by/%D0%A1%D0%B5%D1%80%D1%82%D0%B8%D1%84%D0%B8%D0%BA%D0%B0%D1%82%20GMP%20%D0%95%D0%90%D0%AD%D0%A1.pdf
https://en.triplepharm.by/assets/files/antibiotikorezistentnost_eng.pdf
https://en.triplepharm.by/assets/files/instrukciya-new-rus/Dorenem-instr.PDF
https://en.triplepharm.by/assets/files/instrukciya-new-rus/Dorenem-instr.PDF
https://en.triplepharm.by/assets/files/instrukciya-new-rus/IMP-Kolistat-avg2016.PDF
https://en.triplepharm.by/assets/files/instrukciya-new-rus/IMP-Kolistat-avg2016.PDF
https://en.triplepharm.by/assets/files/instrukciya-new-rus/instrukciya-imicinem.PDF
https://en.triplepharm.by/assets/files/instrukciya-new-rus/instrukciya-imicinem.PDF
https://en.triplepharm.by/assets/files/instrukciya-new-rus/instrukciya-Tejkoplanin-2017.PDF
https://en.triplepharm.by/assets/files/instrukciya-new-rus/instrukciya-Tejkoplanin-2017.PDF
https://en.triplepharm.by/assets/files/instrukciya-new-rus/Instrukciya-Vankomicin.pdf
https://en.triplepharm.by/assets/files/instrukciya-new-rus/Instrukciya-Vankomicin.pdf
https://en.triplepharm.by/assets/files/instrukciya-new-rus/Meropenem-instr.PDF
https://en.triplepharm.by/assets/files/instrukciya-new-rus/Meropenem-instr.PDF
https://en.triplepharm.by/assets/files/kolistin-u-detej-s-MV_eng.pdf
https://en.triplepharm.by/assets/files/new-instr/dorenem-500-mg-dlya-infuzij.pdf
https://en.triplepharm.by/assets/files/new-instr/dorenem-500-mg-dlya-infuzij.pdf
https://en.triplepharm.by/assets/files/new-instr/imicinem-tf-500mg-500-mg-dlya-infuzij.pdf
https://en.triplepharm.by/assets/files/new-instr/imicinem-tf-500mg-500-mg-dlya-infuzij.pdf
https://en.triplepharm.by/assets/files/new-instr/imp-fosfomicin-tf.pdf
https://en.triplepharm.by/assets/files/new-instr/imp-fosfomicin-tf.pdf
https://en.triplepharm.by/assets/files/new-instr/imp_fosfomicin-tf-ing.pdf
https://en.triplepharm.by/assets/files/new-instr/imp_fosfomicin-tf-ing.pdf
https://en.triplepharm.by/assets/files/new-instr/kolistat-1-mln-dlya-ingalyacij.pdf
https://en.triplepharm.by/assets/files/new-instr/kolistat-1-mln-dlya-ingalyacij.pdf
https://en.triplepharm.by/assets/files/new-instr/kolistat-1-mln-me-dlya-vv-vvedeniya.pdf
https://en.triplepharm.by/assets/files/new-instr/kolistat-1-mln-me-dlya-vv-vvedeniya.pdf
https://en.triplepharm.by/assets/files/new-instr/kolistat-2-mln-me-dlya-vv-vvedeniya-i-ingalyacij.pdf
https://en.triplepharm.by/assets/files/new-instr/kolistat-2-mln-me-dlya-vv-vvedeniya-i-ingalyacij.pdf
https://en.triplepharm.by/assets/files/new-instr/meropenem-500-mg-1000-mg-dlya-vv-vvedeniya.pdf
https://en.triplepharm.by/assets/files/new-instr/meropenem-500-mg-1000-mg-dlya-vv-vvedeniya.pdf
https://en.triplepharm.by/assets/files/new-instr/meropenem-500-mg-1000-mg-dlya-vv-vvedeniya.pdf
https://en.triplepharm.by/assets/files/new-instr/tejkoplanin-200-400-dlya-vv-i-vm-vvedeniya.pdf
https://en.triplepharm.by/assets/files/new-instr/tejkoplanin-200-400-dlya-vv-i-vm-vvedeniya.pdf
https://en.triplepharm.by/assets/files/new-instr/vankomicin-500-1000-dlya-infuzij.pdf
https://en.triplepharm.by/assets/files/new-instr/vankomicin-500-1000-dlya-infuzij.pdf
https://en.triplepharm.by/assets/files/new/instrukciya-klaribakcin-en.pdf
https://en.triplepharm.by/assets/files/new/instrukciya-klaribakcin-en.pdf
https://en.triplepharm.by/assets/files/new/klaribakcin.pdf
https://en.triplepharm.by/assets/files/new/klaribakcin.pdf
https://en.triplepharm.by/assets/files/polimiksini_eng.pdf
http://en.triplepharm.by:80/assets/files/Primenenie-Tejkoplanina-TF-u-detej_eng.pdf
https://en.triplepharm.by/assets/files/Primenenie-Tejkoplanina-TF_eng(1).pdf
https://en.triplepharm.by/politika-pers.pdf
https://en.triplepharm.by/politika-pers.pdf
https://en.triplepharm.by/politika-pers.pdf